This is a Phase II, randomized, double-blind, placebo-controlled, parallel-group, multicenter study enrolling patients with active rheumatoid arthritis (RA).
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01225393?cond=%22Arthritis%22&lup_s=08/23/2013&lup_d=30
